Purchases and Sales Made in Q2 2024 in Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX) during Q2 2024. The information is specifically focused on institutions that hold shares of CATALYST PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-150K- 24.15% |
$2.2M - $2.53M
|
470K
$11.3M
|
|
Aug 13, 2024
Q2 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-155K- 15.55% |
$2.27M - $2.62M
|
839K
$20.1M
|
|
Aug 14, 2024
Q2 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-169K- 74.7% |
$2.48M - $2.86M
|
57.2K
$1.37M
|
|
Aug 14, 2024
Q2 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-170K- 90.3% |
$2.5M - $2.88M
|
18.3K
$438K
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-220K- 56.47% |
$3.23M - $3.72M
|
169K
$4.06M
|
|
Aug 14, 2024
Q2 2024
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-234K- 96.49% |
$3.43M - $3.96M
|
8.52K
$204K
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-301K- 61.89% |
$4.42M - $5.1M
|
185K
$4.44M
|
|
Aug 14, 2024
Q2 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-328K- 30.31% |
$4.82M - $5.56M
|
755K
$18.1M
|
|
Aug 14, 2024
Q2 2024
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-364K- 36.28% |
$5.35M - $6.16M
|
640K
$15.3M
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-376K- 76.54% |
$5.51M - $6.36M
|
115K
$2.76M
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-464K- 27.58% |
$6.82M - $7.86M
|
1.22M
$29.2M
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-536K- 47.88% |
$7.86M - $9.06M
|
583K
$14M
|
|
Aug 14, 2024
Q2 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-551K- 20.2% |
$8.08M - $9.32M
|
2.18M
$52.1M
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-786K- 43.7% |
$11.5M - $13.3M
|
1.01M
$24.3M
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-786K- 43.7% |
$11.5M - $13.3M
|
1.01M
$24.3M
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-2.12M- 26.0% |
$31.1M - $35.9M
|
6.03M
$145M
|